Literature DB >> 32902260

RNA Nanoparticles as Rubber for Compelling Vessel Extravasation to Enhance Tumor Targeting and for Fast Renal Excretion to Reduce Toxicity.

Chiran Ghimire1, Hongzhi Wang1, Hui Li1, Mario Vieweger1, Congcong Xu1, Peixuan Guo1.   

Abstract

Rubber is a fascinating material in both industry and daily life. The development of elastomeric material in nanotechnology is imperative due to its economic and technological potential. By virtue of their distinctive physicochemical properties, nucleic acids have been extensively explored in material science. The Phi29 DNA packaging motor contains a 3WJ with three angles of 97°, 125°, and 138°. Here, the rubber-like property of RNA architectures was investigated using optical tweezers and in vivo imaging technologies. The 3WJ 97° interior angle was contracted or stretched to 60°, 90°, and 108° at will to build elegant RNA triangles, squares, pentagons, cubes, tetrahedrons, dendrimers, and prisms. RNA nanoarchitecture was stretchable and shrinkable by optical tweezer with multiple extension and relaxation repeats like a rubber. Comparing to gold and iron nanoparticles with the same size, RNA nanoparticles display stronger cancer-targeting outcomes, while less accumulation in healthy organs. Generally, the upper limit of renal excretion is 5.5 nm; however, the 5, 10, and 20 nm RNA nanoparticles passed the renal filtration and resumed their original structure identified in urine. These findings solve two previous mysteries: (1) Why RNA nanoparticles have an unusually high tumor targeting efficiency since their rubber or amoeba-like deformation property enables them to squeeze out of the leaky vasculature to improve the EPR effect; and (2) why RNA nanoparticles remain non-toxic since they can be rapidly cleared from the body via renal excretion into urine with little accumulation in the body. Considering its controllable shape and size plus its rubber-like property, RNA holds great promises for industrial and biomedical applications especially in cancer therapeutics delivery.

Entities:  

Keywords:  RNA nanotechnology; RNA rubber; elastomer; optical tweezers; pRNA 3WJ motif; rubber-like material

Mesh:

Substances:

Year:  2020        PMID: 32902260      PMCID: PMC7799665          DOI: 10.1021/acsnano.0c04863

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  80 in total

1.  Placement and orientation of individual DNA shapes on lithographically patterned surfaces.

Authors:  Ryan J Kershner; Luisa D Bozano; Christine M Micheel; Albert M Hung; Ann R Fornof; Jennifer N Cha; Charles T Rettner; Marco Bersani; Jane Frommer; Paul W K Rothemund; Gregory M Wallraff
Journal:  Nat Nanotechnol       Date:  2009-08-16       Impact factor: 39.213

2.  The molecular kink paradigm for rubber elasticity: numerical simulations of explicit polyisoprene networks at low to moderate tensile strains.

Authors:  David E Hanson
Journal:  J Chem Phys       Date:  2011-08-07       Impact factor: 3.488

3.  The Mechanical Properties of RNA-DNA Hybrid Duplex Stretched by Magnetic Tweezers.

Authors:  Chen Zhang; Hang Fu; Yajun Yang; Erchi Zhou; Zhijie Tan; Huijuan You; Xinghua Zhang
Journal:  Biophys J       Date:  2018-12-13       Impact factor: 4.033

4.  EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors.

Authors:  Triantafyllos Stylianopoulos
Journal:  Ther Deliv       Date:  2013-04

5.  Controllable Self-Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting.

Authors:  Hui Li; Kaiming Zhang; Fengmei Pi; Sijin Guo; Luda Shlyakhtenko; Wah Chiu; Dan Shu; Peixuan Guo
Journal:  Adv Mater       Date:  2016-06-20       Impact factor: 30.849

6.  Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.

Authors:  Hongran Yin; Gaofeng Xiong; Sijin Guo; Congcong Xu; Ren Xu; Peixuan Guo; Dan Shu
Journal:  Mol Ther       Date:  2019-04-25       Impact factor: 11.454

7.  Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.

Authors:  Sherine Abdelmawla; Songchuan Guo; Limin Zhang; Sai M Pulukuri; Prithviraj Patankar; Patrick Conley; Joseph Trebley; Peixuan Guo; Qi-Xiang Li
Journal:  Mol Ther       Date:  2011-04-05       Impact factor: 11.454

8.  Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes.

Authors:  Ki Tae Nam; Dong-Wan Kim; Pil J Yoo; Chung-Yi Chiang; Nonglak Meethong; Paula T Hammond; Yet-Ming Chiang; Angela M Belcher
Journal:  Science       Date:  2006-04-06       Impact factor: 47.728

Review 9.  The emerging field of RNA nanotechnology.

Authors:  Peixuan Guo
Journal:  Nat Nanotechnol       Date:  2010-11-21       Impact factor: 39.213

Review 10.  Shape-memory polymers.

Authors:  Andreas Lendlein; Steffen Kelch
Journal:  Angew Chem Int Ed Engl       Date:  2002-06-17       Impact factor: 15.336

View more
  15 in total

1.  The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.

Authors:  Morgan Chandler; Brittany Johnson; Emil Khisamutdinov; Marina A Dobrovolskaia; Joanna Sztuba-Solinska; Aliasger K Salem; Koen Breyne; Roger Chammas; Nils G Walter; Lydia M Contreras; Peixuan Guo; Kirill A Afonin
Journal:  ACS Nano       Date:  2021-10-22       Impact factor: 18.027

Review 2.  The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development.

Authors:  Xin Li; Abhjeet S Bhullar; Daniel W Binzel; Peixuan Guo
Journal:  Adv Drug Deliv Rev       Date:  2022-05-05       Impact factor: 17.873

3.  RNA nanotechnology to build a dodecahedral genome of single-stranded RNA virus.

Authors:  Hui Li; Kaiming Zhang; Daniel W Binzel; Lyudmila S Shlyakhtenko; Yuri L Lyubchenko; Wah Chiu; Peixuan Guo
Journal:  RNA Biol       Date:  2021-04-29       Impact factor: 4.652

4.  Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance.

Authors:  Hongzhi Wang; Satheesh Ellipilli; Wen-Jui Lee; Xin Li; Mario Vieweger; Yuan-Soon Ho; Peixuan Guo
Journal:  J Control Release       Date:  2020-12-13       Impact factor: 9.776

Review 5.  Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

Authors:  Daniel W Binzel; Xin Li; Nicolas Burns; Eshan Khan; Wen-Jui Lee; Li-Ching Chen; Satheesh Ellipilli; Wayne Miles; Yuan Soon Ho; Peixuan Guo
Journal:  Chem Rev       Date:  2021-05-26       Impact factor: 72.087

Review 6.  Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects.

Authors:  M Brittany Johnson; Morgan Chandler; Kirill A Afonin
Journal:  Adv Drug Deliv Rev       Date:  2021-04-20       Impact factor: 17.873

7.  Development of targeted therapy therapeutics to sensitize triple-negative breast cancer chemosensitivity utilizing bacteriophage phi29 derived packaging RNA.

Authors:  Long Zhang; Chaofeng Mu; Tinghong Zhang; Dejun Yang; Chenou Wang; Qiong Chen; Lin Tang; Luhui Fan; Cong Liu; Jianliang Shen; Huaqiong Li
Journal:  J Nanobiotechnology       Date:  2021-01-07       Impact factor: 10.435

8.  Stoichiometry of multi-specific immune checkpoint RNA Abs for T cell activation and tumor inhibition using ultra-stable RNA nanoparticles.

Authors:  Dan Shu; Long Zhang; Xuefeng Bai; Jianhua Yu; Peixuan Guo
Journal:  Mol Ther Nucleic Acids       Date:  2021-03-13       Impact factor: 8.886

Review 9.  RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy.

Authors:  Nuannuan Li; Yiying Sun; Yuanlei Fu; Kaoxiang Sun
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

10.  Radiolabeled RNA Nanoparticles for Highly Specific Targeting and Efficient Tumor Accumulation with Favorable In Vivo Biodistribution.

Authors:  Hongzhi Wang; Peixuan Guo
Journal:  Mol Pharm       Date:  2021-07-02       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.